VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.4100
+0.0060 (1.49%)
Dec 11, 2025, 2:06 PM EST - Market open
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $13.65 million as of December 11, 2025. Its market cap has decreased by -69.47% in one year.
Market Cap
13.65M
Enterprise Value
-19.25M
1-Year Change
-69.47%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $13.65M, a decrease of -94.06%. That is a compound annual growth rate of -38.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 13.45M | -72.79% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |